Boston - based start - up Reverie Labs , a graduate of the Y ##ES accelerator , aims to speed up drug development by using machine learning and artificial intelligence ( AI ) to become a fully fledged " molecule - as - a - service " company . It uses machine learning to analyse chemical properties and how they react in the human body , offering suggestions and alternatives to scientists looking to conduct clinical trials . Then it becomes a process of elimination as they narrow down those molecules to ones that not only create the results they want, but are also suitable for animal and human studies. The cloud - based system feeds into third - party workflows , and the company has already partnered with pharmaceutical and biotech companies working on treatments for flu and cancer .
Boston - based start - up Reverie Labs , a graduate of the Y ##ES accelerator , aims to speed up drug development by using machine learning and artificial intelligence ( AI ) to become a fully fledged " molecule - as - a - service " company . It uses machine learning to analyse chemical properties and how they react in the human body , offering suggestions and alternatives to scientists looking to conduct clinical trials . The cloud - based system feeds into third - party workflows , and the company has already partnered with pharmaceutical and biotech companies working on treatments for flu and cancer .